<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Previous studies indicate that the Sigma-1 ligand 4-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-1-(4-phenylbutyl) <z:chebi fb="0" ids="18049">piperidine</z:chebi> (PPBP) protects the brain from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Less clear is whether protection is mediated by agonism or antagonism of the Sigma-1 receptor, and whether drugs already in use for other indications and that interact with the Sigma-1 receptor might also prevent oxidative damage due to conditions such as cerebral <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="0" ids="35476">antipsychotic drug</z:chebi> <z:chebi fb="6" ids="5613">haloperidol</z:chebi> is an <z:chebi fb="68" ids="48706">antagonist</z:chebi> of Sigma-1 receptors and in this study it potently protects against <z:mp ids='MP_0003674'>oxidative stress</z:mp>-related cell <z:hpo ids='HP_0011420'>death</z:hpo> in vitro at low concentrations </plain></SENT>
<SENT sid="3" pm="."><plain>The protective potency of <z:chebi fb="6" ids="5613">haloperidol</z:chebi> and a number of other butyrophenone compounds positively correlate with their affinity for a cloned Sigma-1 receptor, and the protection is mimicked by a Sigma-1 receptor-selective <z:chebi fb="68" ids="48706">antagonist</z:chebi> (BD1063), but not an <z:chebi fb="4" ids="48705">agonist</z:chebi> (PRE-084) </plain></SENT>
<SENT sid="4" pm="."><plain>In vivo, an <z:hpo ids='HP_0011009'>acute</z:hpo> low dose (0.05 mg/kg s.c.) of <z:chebi fb="6" ids="5613">haloperidol</z:chebi> reduces by half the ischemic lesion volume induced by a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>These in vitro and in vivo pre-clinical results suggest that a low dose of acutely administered <z:chebi fb="6" ids="5613">haloperidol</z:chebi> might have a novel application as a <z:chebi fb="1" ids="50267">protective agent</z:chebi> against ischemic cerebral <z:hpo ids='HP_0001297'>stroke</z:hpo> and other types of brain injury with an ischemic component </plain></SENT>
</text></document>